I Still Can't Believe Danaher Is Paying Only $20 Billion to Buy This Business From General Electric
Following General Electric's (NYSE: GE) third-quarter earnings report, it became clear that when Danaher (NYSE: DHR) completes its acquisition of GE's biopharma business in 2020, it will be getting the growth business of GE Healthcare. Moreover, the recent GE Healthcare investor day only served to reinforce the idea that Danaher is getting a great bargain in the deal.
Here's why, and what it means to both sets of investors.
Image source: Getty Images.
Source Fool.com
